Rankings
▼
Calendar
PMVP (PMV Pharmaceuticals, Inc.) Stock Financials & Earnings | Market Cap Arena
PMVP
PMV Pharmaceuticals, Inc.
Mkt Cap
$88M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$83M
EPS (TTM)
-$0.78
Free Cash Flow (TTM)
-$73M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 22
$0
$0
-$21M
Q1 23
$0
$0
-$21M
Q2 23
$0
$0
-$20M
Q3 23
$0
$0
-$20M
Q4 23
$0
-$359K
-$19M
Q1 24
$0
-$362K
-$18M
Q2 24
$0
-$372K
-$20M
Q3 24
$0
$0
-$22M
Q4 24
$0
$0
-$25M
Q1 25
$0
$0
-$22M
Q2 25
$0
-$32K
-$23M
Q3 25
$0
-$32K
-$23M
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 22
-$15M
-$17M
Q1 23
-$15M
-$15M
Q2 23
-$13M
-$13M
Q3 23
-$16M
-$16M
Q4 23
-$12M
-$12M
Q1 24
-$16M
-$17M
Q2 24
-$2M
-$2M
Q3 24
-$17M
-$17M
Q4 24
-$17M
-$17M
Q1 25
-$18M
-$18M
Q2 25
-$18M
-$18M
Q3 25
-$20M
-$20M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 22
$2M
Q1 23
$156K
Q2 23
$565K
Q3 23
$44K
Q4 23
$197K
Q1 24
$594K
Q2 24
$4K
Q3 24
$1K
Q4 24
$56K
Q1 25
$4K
Q2 25
$11K
Q3 25
$1K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 22
—
+14.6%
Q1 23
—
+15.4%
Q2 23
—
+12.5%
Q3 23
—
+1.3%
Q4 23
—
-10.7%
Q1 24
—
-15.2%
Q2 24
—
+0.2%
Q3 24
—
+11.5%
Q4 24
—
+33.1%
Q1 25
—
+18.3%
Q2 25
—
+13.4%
Q3 25
—
+2.9%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 22
$0
—
Q1 23
$0
—
Q2 23
$3M
—
Q3 23
$3M
—
Q4 23
$3M
—
Q1 24
$3M
—
Q2 24
$3M
—
Q3 24
$2M
—
Q4 24
$1M
—
Q1 25
$2M
—
Q2 25
$2M
—
Q3 25
$0
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q4 22
$15M
$6M
—
Q1 23
$15M
$6M
—
Q2 23
$14M
$6M
—
Q3 23
$14M
$6M
—
Q4 23
$13M
—
$6M
Q1 24
$13M
$5M
—
Q2 24
$14M
$6M
—
Q3 24
$17M
$5M
—
Q4 24
$14M
$11M
—
Q1 25
$17M
$4M
—
Q2 25
$18M
$4M
—
Q3 25
$18M
—
$4M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$143M
$86M
$229M
Q2 23
$68M
$119M
$187M
Q3 23
$52M
$150M
$202M
Q4 23
$38M
$165M
$203M
Q1 24
$48M
$150M
$198M
Q2 24
$49M
$164M
$213M
Q3 24
$49M
$134M
$183M
Q4 24
$41M
$129M
$169M
Q1 25
$51M
$109M
$160M
Q2 25
$44M
$98M
$142M
Q3 25
$36M
$93M
$129M
Q4 25
$38M
$75M
$113M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 22
46M
+0.2%
Q1 23
46M
+0.2%
Q2 23
46M
+0.1%
Q3 23
49M
+7.1%
Q4 23
51M
+4.9%
Q1 24
51M
+0.0%
Q2 24
51M
+0.1%
Q3 24
52M
+0.2%
Q4 24
52M
+0.0%
Q1 25
52M
+0.7%
Q2 25
52M
+0.1%
Q3 25
53M
+1.9%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 18
—
—
FY 19
—
—
FY 20
$0
44
FY 21
$0
54
FY 22
$0
62
FY 23
$0
63
FY 24
$0
47
FY 25
$0
200K
marketcaparena.com